Danny Davis

Danny Davis is Senior Vice President at HEST Investments, a Dallas based family office investing in early stage life sciences and select quantum enabling technologies and infrastructure. His work spans investment evaluation, due diligence, financing strategy, and portfolio company support. He has led seed financings with HEST as lead investor, helped
build investor syndicates, and worked with management teams on budgeting, fundraising, and business strategy.

Danny brings both an investor’s and an operator’s perspective to evaluating opportunities and building companies. His background spans pharmaceutical development, business development, and capital strategy, with board and board observer experience across HEST portfolio companies. 

He holds a PharmD, a PhD in Molecular Pharmaceutics and Drug Delivery, and an MBA through the Executive MBA program at The University of Texas at Austin.